Colinz Laboratories Approves Quarterly Results, Announces CEO and Director Appointments

Colinz Laboratories Approves Quarterly Results, Announces CEO and Director Appointments​

Colinz Laboratories Ltd held a Board of Directors meeting on July 30, 2026, during which it reviewed its unaudited financial results for the quarter ended June 30, 2026. The meeting also saw several key appointments made regarding the company’s governance and management structure.

The company confirmed that the statutory auditors conducted a limited review of the unaudited results. These results were approved by the Board alongside the Directors' Report and the Management Discussion Report for the year ended March 31, 2026. The board also took note of the Secretarial Audit Report issued by M/s. Sanjay Dholakia & Associates for the financial year ended March 31, 2026.

The Board meeting finalized operational details for the upcoming Annual General Meeting (AGM) and set the Register of Members closure period from September 15, 2026, to September 20, 2026. The cutoff date for determining eligible shareholders for electronic voting was set as September 14, 2026.

Financial Performance Snapshot​

The unaudited financial results for the quarter ended June 30, 2026, showed Total Income from Operation at 136.26 (Rs. in Lakhs). Expenses were reported at 122.47, leading to a Profit before tax of 290.12.

The comparative financial data is summarized below:

Key Governance and Management Appointments​

The Board made several decisions regarding the company's leadership structure:

• CEO and Whole time Director: The board discussed, approved, and recommended the appointment of Mr. N K Menon as Whole time Director and CEO for a term of one year, effective from October 1, 2026, to September 30, 2027. This appointment is subject to approval by members in the forthcoming Annual General Meeting.
• Director Promoter: The company considered and approved the appointment of Mrs. Vijaya Mani (DIN 11363910) as a Director Promoter and Non-Executive Director, liable to retire by rotation, effective from the next rotating annual General Meeting, pending member approval.
• Auditor Appointments: M/s. Sanjay Dholakia & Associates were appointed as Secretarial Auditor for the financial year ending March 31, 2027. Concurrently, CA Ajay Ramsevak Sharma was approved as the Internal Auditor of the Company for the Financial Year 2026-27.

The company is primarily engaged in the manufacturing of Pharmaceutical Formulations. The Board noted that during the reporting quarter, the company received the final tranche of proceeds from the sale of factory land, building and machinery at Sinnar, Maharashtra, though manufacturing activities at that location continue on a loan license/third party basis.

Stock Price Movement​

Colinz Laboratories Ltd settled at ₹80.00 today, climbing 1.52% after the market close. The shares moved within a range defined by the intraday low of ₹74.86 and high of ₹82.00.